SlideShare a Scribd company logo
Environmental Microbial
Monitoring (EMM)
環境微生物監控
吳淑華
阮綜合醫院迴旋加速器中心
USP Regulations
• <51> Antimicrobial effectiveness testing
• <61> Microbiological examination of nonsterile products:
microbial enumeration tests
• <62> Microbiological examination of nonsterile products:
tests for specified microorganisms
• <71> Sterility tests
• <1113> Microbial characterization identification and strain typing
• <1116> Microbiological control and monitoring of aseptic
processing environments
• <1117> Microbiological Best Laboratory Practices
• <1227> Validation of microbial recovery from
pharmacopeial articles
2017/3/4 2
Purpose of EM
• Critical process within the pharmaceutical industries.
• Determines the microbial and particulate content of
cleanroom air and surfaces.
• Highlights conditions contributing to excessive microbial &
particulate levels due to ineffective cleaning, or
personnel/equipment issues (Trending).
• Alerts to conditions exceeding classifications.
• Proactive tool for Quality Assurance.
2017/3/4 3
Who Does It?
• Quality Control
– Demonstrate product safety
– Environmental Monitoring
– Testing
• Quality Assurance
– Oversight responsibilities – ensure compliance with GMPs
– Review and Approve all Records, Reports, written
procedures, specifications
– Audit methods, results, systems and processes
2017/3/4 4
To be monitored
• Non-viable airborne particulates
• Viable airborn particulates
• Viable surface bound particulates on cleanroom surfaces
and personnel
• Contamination Sources
– People ~75%
– Ventilation ~15%
– Room Structure ~5%
– Equipment ~5%
2017/3/4 5
USP 39 <1116>
• Studies indicate that gowned humans slough particulate and
microbial contamination at a rather consistent rate.
• Where equipment is the primary source of particulate matter,
the resulting particulates are essentially all nonviable.
• It is not possible to clearly distinguish between background
total particulate contamination generated largely by
mechanical operations and the total particulates contributed by
personnel. both a total particulate component and a
microbiological component.
2017/3/4 6
Classifications & Control Level
USP39 <1116>
2017/3/4 7
USP34 <1116> Microbial considerations and Action
levels for Controlled Environment
2017/3/4 8
FDA(2004)
1
10
100
USP39 <1116> Suggested Initial Contamination Recovery
Rates(CRR) in Aseptic Environments
Room Classification Active air Sample
(%)
Settle Plates(9cm)
4hr Exposure(%)
Contact Plates or
Swab(%)
Glove or Garment
(%)
Isolator/Closed
RABS
(ISO 5 or better)
<0.1 <0.1 <0.1 <0.1
ISO 5 <1 <1 <1 <1
ISO 6 <3 <3 <3 <3
ISO 7 <5 <5 <5 <5
ISO 8 <10 <10 <10 <10
2017/3/4 9
EU and FDA recommended limits for microbial contamination
PIC/S Annex 1 PE 009-13(2017) (top) ,FDA Pharmaceutical CGMPs (2004) (bottom)
Grade Air Sample
cfu/m3
Settle Plates
(Ø 90mm), cfu/4hrs
Contact Plates
(Ø 55mm), cfu/plate
Glove Print 5
Fingers, cfu/glove
A <1 <1 <1 <1
B 10 5 5 5
C 100 50 25 -
D 200 100 50 -
Clean Area Classification
(0.5μm particles/cfu)
ISO Designation Air Sample
cfu/m3
Settle Plates
(Ø 90mm), cfu/4hrs
100 ISO 5 1 1
1000 ISO 6 7 3
10000 ISO 7 10 5
100000 ISO 8 100 50
2017/3/4 10
Sampling Plain
• Frequency
• Time
• Sites
• Method
2017/3/4 11
Sampling Frequency
• The frequency of sampling depends on the manufacturing
process conducted within an environment.
• Classified environments in which closed manufacturing
operations are conducted, including fermentation, sterile API
processing, and chemical processes, require fewer
monitoring sites and less frequent monitoring because the
risk of microbial contamination from the surrounding
environment is comparatively low.
2017/3/4 12
Sampling Frequency (cont.)
• It is not possible to recommend microbial control levels for
each type of manufacturing environment. depending on
the production activities
• Monitoring should reflect the microbiological control
requirements of manufacturing or processing activities.
• Formal risk assessment techniques can result in a
scientifically valid contamination control program.
2017/3/4 13
USP39 <1116>
ESTABLISHMENT OF SAMPLING PLAN AND SITES
2017/3/4 14
Sampling Time
• Sampling should take place with the facility in the
operational condition (personnel present and normal
operations being carried out).
• Microbial sampling should occur when materials are in the
area, processing activities are ongoing, and a full
complement of personnel is working within the aseptic
processing environment.
• The operational condition for sterile hoods and transfer
devices can be considered to be when an operator is
working in any part of the clean air device.
• Sampling in the static condition should be performed at an
agreed frequency to monitor baseline contamination levels.
2017/3/4 15
Sampling Sites
• Microbial monitoring of manufacturing clean rooms, RABS,
and isolators should include compressed gases, surfaces,
room or enclosure air, and any other materials and
equipment that might produce a risk of contamination.
• The location and movement of personnel within the clean
room correlate with contamination risk to the environment
and to the processes conducted within that environment.
• The location and movement of personnel within the clean
room correlate with contamination risk to the environment
and to the processes conducted within that environment.
2017/3/4 16
Methods of EMM
• Air
- Air sampler(active method): testing of the number of
organisms per volume of air sampled.
-Settling plate(passive method): settling plates can be
used as qualitative, or semi-qualitat
• Surface
-Contact plate: product contact surface, floors, walls,
and equipment should be tested on a
regular basis.
-Swabbing
2017/3/4 17
Air Sampler
(Viable airborne particulates)
Active Air Monitoring
ISO 14644, Fed Std-209E, USP <1116>
• Used to sample a defined volume of air, embedding viable
particulates onto sterile media strips.
• The media strips are incubated to promote the growth of
viable particulates
• The microorganisms are counted and results are reported as
the number of CFU per volume of air sampled.
2017/3/4 18
Settling Plates
(Viable airborne particulates)
Passive Air Monitoring
ISO 14644, Fed Std-209E, USP <1116>
• Settling plates filled with media are used to sample the
microbial fallout over time.
• The plates are incubated to promote growth
• Microorganisms are counted and results are reported as the
number of CFU per time sampled.
• The average size of microbial particle will deposit, by gravity,
onto surfaces at a rate of approximately 1 cm/s.
2017/3/4 19
Sampling Sites for Settling Plates
• Areas where there is little air movement (i.e. "dead spaces")
or where airflows converge or are excessively turbulent.
These conditions are most likely to occur:
– adjacent to doors
– in pass through hatches
– at low level return air grilles
– between HEPA's in clean rooms
– in corners of rooms
• Areas within the clean room where there is personnel
activity or where specific operations are carried out.
2017/3/4 20
RODAC Plates
(Viable, Surface-Bound Particles)
Surface Monitoring
ISO 14644, Fed Std-209E, USP <1116>
• Contact plates (RODAC Plates) filled with media are used to
sample tabletops, walls, benches, floors, garments, and
gowned personnel.
• Measure the number of microorganisms per area sampled.
• Plates are incubated to promote growth, the microorganisms
are counted and results are reported as the number of CFU
per area sampled.
2017/3/4 21
RODAC
(Replicate Organism Detection and Counting)
• flat agar surface is above the edges of the dish (so you can press
it on flat surfaces) and a grid, allowing counting of cfu per cm².
2017/3/4 22
RODAC Plates
• One objective of surface sampling is to determine the efficiency of
routine cleaning procedures in removing contamination.
- Sampling is done before and after cleaning.
- The medium in the plates contains neutralizing agents,
which inactivate residual disinfectants on the surface to be
tested, allowing comparative results before and after
cleaning.
• RODAC plates are also used to monitor the contamination level of
personnel gowns and Personal Protective Equipment (PPE) before
or during manufacturing production.
2017/3/4 23
Swabbing method
(Viable, Surface-Bound Particles)
Surface Monitoring
ISO 14644, Fed Std-209E, USP <1116>
• The swabbing method can be used to supplement contact
plates for sampling of irregular surfaces, especially irregular
surfaces of equipment.
• The area that will be swabbed is defined with a sterile template
of appropriate size.
• In general, it is in the range of 24–30 cm2.
• After sample collection the swab is placed in an appropriate
diluent or transport medium and is plated onto the desired
nutrient agar.
2017/3/4 24
2017/3/4 25
Rapid Microbiological Methods
Contact Slide(25cm2) Petrifilm plate
• USP<61> <62> <71> <1227>
2017/3/4 26
Growth Media
• Use a growth medium with low selectivity i.e. capable of
supporting a broad spectrum of microorganisms including
bacteria, fungi, yeast and molds.
- SCDM(TSA) is suitable for environmental monitoring in
most cases because it supports the growth of a wide range
of bacteria, yeast, and molds.
- Sabouraud Dextrose Agar (SDA) supports yeast and fungal
colonies.
2017/3/4 27
Growth Media
• When necessary to detect or search for a particular type of
microorganism a selective culture medium should be used.
- Malt Extract Agar(MEA) is used as a general purpose growth
media to isolate and cultivate yeasts and molds from
clinical samples, as well as a wide range of environmental
sources.
2017/3/4 28
Culture Condition
USP 39 <1116>
• Typically, for general microbiological growth media such
as SCDM, incubation temperatures in the ranges of
approximately 20 –35℃ have been used with an incubation
time of not less than 72 hours.
• The temperature ranges given above are by no means
absolute.
• For many mesophilic organisms, recovery is possible over a
range of approximately 20℃ .
2017/3/4 29
Culture Condition
USP 39 <1116>
•In the absence of confirmatory evidence, microbiologists
may incubate a single plate at both a low and a higher
temperature. Incubating at the lower temperature first may
compromise the recovery of Gram(+) cocci that are
important because they are often associated with humans.
•Typically, for general microbiological growth media such as
SCDM, incubation temperatures in the ranges of
approximately 20–35℃ have been used with an incubation
time of not less than 72 hours.
- TSA plates are incubated at 30-35°C for 3 days.
- SDA plates are incubated at 20-25°C for 5 days.
(A review of cleanroom microflora: Types, treans, and Pattens. PDA J Pharm Sci Technol ,2011)
2017/3/4 30
Identification
• FDA Pharmaceutical CGMPs, 2004
2017/3/4 31
• FDA Pharmaceutical CGMPs, 2004
2017/3/4 32
• USP 39 <1116> Identification of microbial isolates
2017/3/4 33
Gowning Procedure
2017/3/4 34
2017/3/4
35
2017/3/4 36
Questions
2017/3/4 37
USP39 <1117>
• Special care should be taken with media that is used in
environmental monitoring studies. Media used for
environmental monitoring of critical areas should preferably
be double-wrapped and terminally sterilized. If terminal
sterilization is not performed, media should be subjected to
pre-incubation and 100% inspection prior to use within a
critical area. This will prevent extraneous contamination
from being carried into controlled environments and will
prevent false-positive results. A raised agar level for surface
contact plates should be verified.
2017/3/4 38

More Related Content

What's hot

Environmental Monitoring of Clean Room
Environmental Monitoring of Clean RoomEnvironmental Monitoring of Clean Room
Environmental Monitoring of Clean Room
Iqra Shafeeq
 
Risk Management in Sterile Environments
Risk Management in Sterile Environments Risk Management in Sterile Environments
Risk Management in Sterile Environments
Tim Sandle, Ph.D.
 
WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.
GMP EDUCATION : Not for Profit Organization
 
Pharmaceutical environment monitoring
Pharmaceutical environment monitoringPharmaceutical environment monitoring
Pharmaceutical environment monitoring
Aslam Ali
 
Aseptic Processing & Media Fill
Aseptic Processing & Media FillAseptic Processing & Media Fill
Aseptic Processing & Media Fill
Muhammad Luqman Ikram
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
Prakash Ghimire
 
Process analytical technology
Process analytical technologyProcess analytical technology
Process analytical technology
Vivekanandan S
 
Cross contamination
Cross contaminationCross contamination
Cross contamination
kiranreddy munnangi
 
Presentation: Cleaning Validation
Presentation: Cleaning ValidationPresentation: Cleaning Validation
Presentation: Cleaning Validation
TGA Australia
 
USP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on MicrobiologyUSP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on Microbiology
Tim Sandle, Ph.D.
 
Microbiology lab QC
Microbiology lab QCMicrobiology lab QC
Microbiology lab QC
Mostafa Mahmoud
 
Water system validation
Water system validationWater system validation
Water system validation
Malla Reddy College of Pharmacy
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
MANIKANDAN V
 
Qualification of Autoclave - Dipankar.pptx
Qualification of Autoclave - Dipankar.pptxQualification of Autoclave - Dipankar.pptx
Qualification of Autoclave - Dipankar.pptx
GNIPST
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operation
Tim Sandle, Ph.D.
 
cleaning validation for SSP.pptx
cleaning validation for SSP.pptxcleaning validation for SSP.pptx
cleaning validation for SSP.pptx
SurafelKebede5
 
Cleaning room basics
Cleaning room basicsCleaning room basics
Cleaning room basics
AlliedModular
 
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile PharmaceuticalsWho Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile Pharmaceuticals
GMP EDUCATION : Not for Profit Organization
 

What's hot (20)

Environmental Monitoring of Clean Room
Environmental Monitoring of Clean RoomEnvironmental Monitoring of Clean Room
Environmental Monitoring of Clean Room
 
Risk Management in Sterile Environments
Risk Management in Sterile Environments Risk Management in Sterile Environments
Risk Management in Sterile Environments
 
ISO 14644-1
ISO 14644-1ISO 14644-1
ISO 14644-1
 
WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.
 
CLEANING VALIDATION-NS
CLEANING VALIDATION-NSCLEANING VALIDATION-NS
CLEANING VALIDATION-NS
 
Pharmaceutical environment monitoring
Pharmaceutical environment monitoringPharmaceutical environment monitoring
Pharmaceutical environment monitoring
 
Aseptic Processing & Media Fill
Aseptic Processing & Media FillAseptic Processing & Media Fill
Aseptic Processing & Media Fill
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
 
Process analytical technology
Process analytical technologyProcess analytical technology
Process analytical technology
 
Cross contamination
Cross contaminationCross contamination
Cross contamination
 
Presentation: Cleaning Validation
Presentation: Cleaning ValidationPresentation: Cleaning Validation
Presentation: Cleaning Validation
 
USP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on MicrobiologyUSP &lt;1116> and its impact on Microbiology
USP &lt;1116> and its impact on Microbiology
 
Microbiology lab QC
Microbiology lab QCMicrobiology lab QC
Microbiology lab QC
 
Water system validation
Water system validationWater system validation
Water system validation
 
Quality by Design and Process Analytical Technology
Quality by Design and Process Analytical TechnologyQuality by Design and Process Analytical Technology
Quality by Design and Process Analytical Technology
 
Qualification of Autoclave - Dipankar.pptx
Qualification of Autoclave - Dipankar.pptxQualification of Autoclave - Dipankar.pptx
Qualification of Autoclave - Dipankar.pptx
 
Risk analysis in sterile operation
Risk analysis in sterile operationRisk analysis in sterile operation
Risk analysis in sterile operation
 
cleaning validation for SSP.pptx
cleaning validation for SSP.pptxcleaning validation for SSP.pptx
cleaning validation for SSP.pptx
 
Cleaning room basics
Cleaning room basicsCleaning room basics
Cleaning room basics
 
Who Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile PharmaceuticalsWho Guidance on Process Validation for Non Serile Pharmaceuticals
Who Guidance on Process Validation for Non Serile Pharmaceuticals
 

Similar to 1116 Added.pdf

Environmental monitoring - viable particle sampling
Environmental monitoring - viable particle samplingEnvironmental monitoring - viable particle sampling
Environmental monitoring - viable particle sampling
Jerry Fahrni
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
Nosheen_Sheikh45
 
Environmental Monitoring in operation mm
Environmental Monitoring in operation mmEnvironmental Monitoring in operation mm
Environmental Monitoring in operation mm
MohnmadZaitoon
 
Aseptic filling
Aseptic fillingAseptic filling
Aseptic filling
BUCHIRAJUVENKATASRAV
 
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
A Brief Overview on Active Air Sampling Procedure for Environment MonitoringA Brief Overview on Active Air Sampling Procedure for Environment Monitoring
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
ijtsrd
 
STERILE Prpn.pptx
STERILE Prpn.pptxSTERILE Prpn.pptx
STERILE Prpn.pptx
Anuradha Mishra
 
Sterile Drug Products produced by cGMP
Sterile Drug Products produced by cGMPSterile Drug Products produced by cGMP
Sterile Drug Products produced by cGMP
Iqra Shafeeq
 
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùngPhụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical productsTRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
Công ty cổ phần GMPc Việt Nam | Tư vấn GMP, HS GMP, CGMP ASEAN, EU GMP, WHO GMP
 
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical productsTrs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical productsQC at MinhDan Pharmaceutical
 
Environmental Characterization of Controlled Rooms
Environmental Characterization of Controlled RoomsEnvironmental Characterization of Controlled Rooms
Environmental Characterization of Controlled Rooms
angelsalaman
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technology
PriyankaSananse
 
Aseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptxAseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptx
NaeemSarwar37
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptx
zohaibmaqsoodneutrop
 
opthalmics.pptx
opthalmics.pptxopthalmics.pptx
opthalmics.pptx
TridevSastri1
 
Bioburden
Bioburden  Bioburden
Bioburden
vedshree raole
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Institute of Validation Technology
 
ENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORINGENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING
Srinath Sasidharan
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processingShivaram
 

Similar to 1116 Added.pdf (20)

Environmental monitoring - viable particle sampling
Environmental monitoring - viable particle samplingEnvironmental monitoring - viable particle sampling
Environmental monitoring - viable particle sampling
 
Environmental monitoring
Environmental monitoringEnvironmental monitoring
Environmental monitoring
 
Environmental Monitoring in operation mm
Environmental Monitoring in operation mmEnvironmental Monitoring in operation mm
Environmental Monitoring in operation mm
 
Aseptic filling
Aseptic fillingAseptic filling
Aseptic filling
 
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
A Brief Overview on Active Air Sampling Procedure for Environment MonitoringA Brief Overview on Active Air Sampling Procedure for Environment Monitoring
A Brief Overview on Active Air Sampling Procedure for Environment Monitoring
 
STERILE Prpn.pptx
STERILE Prpn.pptxSTERILE Prpn.pptx
STERILE Prpn.pptx
 
Sterile Drug Products produced by cGMP
Sterile Drug Products produced by cGMPSterile Drug Products produced by cGMP
Sterile Drug Products produced by cGMP
 
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùngPhụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
Phụ lục 6. Tiêu chuẩn GMP WHO cho chế phẩm vô trùng
 
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical productsTRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
TRS 961 (2011) - Annex 6 - WHO GMP for sterile pharmaceutical products
 
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical productsTrs 961 (2011)   annex 6 - who gmp for sterile pharmaceutical products
Trs 961 (2011) annex 6 - who gmp for sterile pharmaceutical products
 
Environmental Characterization of Controlled Rooms
Environmental Characterization of Controlled RoomsEnvironmental Characterization of Controlled Rooms
Environmental Characterization of Controlled Rooms
 
Advanced sterile product manufacturing technology
Advanced sterile product manufacturing technologyAdvanced sterile product manufacturing technology
Advanced sterile product manufacturing technology
 
Aseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptxAseptic Technique for sterile area .pptx
Aseptic Technique for sterile area .pptx
 
cGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptxcGMP of sterile area by faheem sb.pptx
cGMP of sterile area by faheem sb.pptx
 
opthalmics.pptx
opthalmics.pptxopthalmics.pptx
opthalmics.pptx
 
Bioburden
Bioburden  Bioburden
Bioburden
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
 
ENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORINGENVIRONMENTAL MONITORING
ENVIRONMENTAL MONITORING
 
xyz
xyzxyz
xyz
 
Aseptic processing
Aseptic processingAseptic processing
Aseptic processing
 

More from Balaji Kuzhandhaivelu

usp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptxusp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptx
Balaji Kuzhandhaivelu
 
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptxMICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
Balaji Kuzhandhaivelu
 
pharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdfpharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdf
Balaji Kuzhandhaivelu
 
general-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.pptgeneral-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.ppt
Balaji Kuzhandhaivelu
 
presentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdfpresentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdf
Balaji Kuzhandhaivelu
 

More from Balaji Kuzhandhaivelu (6)

usp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptxusp1116presmar2016-160306010258.pptx
usp1116presmar2016-160306010258.pptx
 
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptxMICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
MICROBIOLOGICAL EXAMINATION OF NONSTERILE PRODUCTS SPECIFIC ORGANISMS.pptx
 
BET.pptx
BET.pptxBET.pptx
BET.pptx
 
pharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdfpharmaceuticalmicrobiology-190210072912.pdf
pharmaceuticalmicrobiology-190210072912.pdf
 
general-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.pptgeneral-introduction-2017-1-klein.ppt
general-introduction-2017-1-klein.ppt
 
presentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdfpresentation-ema-experience-mdr-implementation_en.pdf
presentation-ema-experience-mdr-implementation_en.pdf
 

Recently uploaded

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cell
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
Naeemshahzad51
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
Sachin Sharma
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
ranishasharma67
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Guillermo Rivera
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
pchutichetpong
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
Radhika kulvi
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
fprxsqvnz5
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
Aboud Health Group
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
rajkumar669520
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
RitonDeb1
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
ranishasharma67
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
samahesh1
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
ssuser787e5c1
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
Care Coordinations
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
Ameena Kadar
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
ILC- UK
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
ranishasharma67
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
ranishasharma67
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
Kumar Satyam
 

Recently uploaded (20)

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx
 
Dimensions of Healthcare Quality
Dimensions of Healthcare QualityDimensions of Healthcare Quality
Dimensions of Healthcare Quality
 
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfCHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf
 
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
Contact ME {89011**83002} Haridwar ℂall Girls By Full Service Call Girl In Ha...
 
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...
 
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...Medical Technology Tackles New Health Care Demand - Research Report - March 2...
Medical Technology Tackles New Health Care Demand - Research Report - March 2...
 
Health Education on prevention of hypertension
Health Education on prevention of hypertensionHealth Education on prevention of hypertension
Health Education on prevention of hypertension
 
Introduction to Forensic Pathology course
Introduction to Forensic Pathology courseIntroduction to Forensic Pathology course
Introduction to Forensic Pathology course
 
Navigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and BeyondNavigating Women's Health: Understanding Prenatal Care and Beyond
Navigating Women's Health: Understanding Prenatal Care and Beyond
 
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...
 
Myopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptxMyopia Management & Control Strategies.pptx
Myopia Management & Control Strategies.pptx
 
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICEJaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
 
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD
 
the IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meetingthe IUA Administrative Board and General Assembly meeting
the IUA Administrative Board and General Assembly meeting
 
Essential Metrics for Palliative Care Management
Essential Metrics for Palliative Care ManagementEssential Metrics for Palliative Care Management
Essential Metrics for Palliative Care Management
 
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......POLYCYSTIC OVARIAN SYNDROME (PCOS)......
POLYCYSTIC OVARIAN SYNDROME (PCOS)......
 
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...
 
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
Haridwar ❤CALL Girls 🔝 89011★83002 🔝 ❤ℂall Girls IN Haridwar ESCORT SERVICE❤
 
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
GURGAON Call Girls ❤8901183002❤ #ℂALL# #gIRLS# In GURGAON ₹,2500 Cash Payment...
 
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...
 

1116 Added.pdf

  • 2. USP Regulations • <51> Antimicrobial effectiveness testing • <61> Microbiological examination of nonsterile products: microbial enumeration tests • <62> Microbiological examination of nonsterile products: tests for specified microorganisms • <71> Sterility tests • <1113> Microbial characterization identification and strain typing • <1116> Microbiological control and monitoring of aseptic processing environments • <1117> Microbiological Best Laboratory Practices • <1227> Validation of microbial recovery from pharmacopeial articles 2017/3/4 2
  • 3. Purpose of EM • Critical process within the pharmaceutical industries. • Determines the microbial and particulate content of cleanroom air and surfaces. • Highlights conditions contributing to excessive microbial & particulate levels due to ineffective cleaning, or personnel/equipment issues (Trending). • Alerts to conditions exceeding classifications. • Proactive tool for Quality Assurance. 2017/3/4 3
  • 4. Who Does It? • Quality Control – Demonstrate product safety – Environmental Monitoring – Testing • Quality Assurance – Oversight responsibilities – ensure compliance with GMPs – Review and Approve all Records, Reports, written procedures, specifications – Audit methods, results, systems and processes 2017/3/4 4
  • 5. To be monitored • Non-viable airborne particulates • Viable airborn particulates • Viable surface bound particulates on cleanroom surfaces and personnel • Contamination Sources – People ~75% – Ventilation ~15% – Room Structure ~5% – Equipment ~5% 2017/3/4 5
  • 6. USP 39 <1116> • Studies indicate that gowned humans slough particulate and microbial contamination at a rather consistent rate. • Where equipment is the primary source of particulate matter, the resulting particulates are essentially all nonviable. • It is not possible to clearly distinguish between background total particulate contamination generated largely by mechanical operations and the total particulates contributed by personnel. both a total particulate component and a microbiological component. 2017/3/4 6
  • 7. Classifications & Control Level USP39 <1116> 2017/3/4 7
  • 8. USP34 <1116> Microbial considerations and Action levels for Controlled Environment 2017/3/4 8 FDA(2004) 1 10 100
  • 9. USP39 <1116> Suggested Initial Contamination Recovery Rates(CRR) in Aseptic Environments Room Classification Active air Sample (%) Settle Plates(9cm) 4hr Exposure(%) Contact Plates or Swab(%) Glove or Garment (%) Isolator/Closed RABS (ISO 5 or better) <0.1 <0.1 <0.1 <0.1 ISO 5 <1 <1 <1 <1 ISO 6 <3 <3 <3 <3 ISO 7 <5 <5 <5 <5 ISO 8 <10 <10 <10 <10 2017/3/4 9
  • 10. EU and FDA recommended limits for microbial contamination PIC/S Annex 1 PE 009-13(2017) (top) ,FDA Pharmaceutical CGMPs (2004) (bottom) Grade Air Sample cfu/m3 Settle Plates (Ø 90mm), cfu/4hrs Contact Plates (Ø 55mm), cfu/plate Glove Print 5 Fingers, cfu/glove A <1 <1 <1 <1 B 10 5 5 5 C 100 50 25 - D 200 100 50 - Clean Area Classification (0.5μm particles/cfu) ISO Designation Air Sample cfu/m3 Settle Plates (Ø 90mm), cfu/4hrs 100 ISO 5 1 1 1000 ISO 6 7 3 10000 ISO 7 10 5 100000 ISO 8 100 50 2017/3/4 10
  • 11. Sampling Plain • Frequency • Time • Sites • Method 2017/3/4 11
  • 12. Sampling Frequency • The frequency of sampling depends on the manufacturing process conducted within an environment. • Classified environments in which closed manufacturing operations are conducted, including fermentation, sterile API processing, and chemical processes, require fewer monitoring sites and less frequent monitoring because the risk of microbial contamination from the surrounding environment is comparatively low. 2017/3/4 12
  • 13. Sampling Frequency (cont.) • It is not possible to recommend microbial control levels for each type of manufacturing environment. depending on the production activities • Monitoring should reflect the microbiological control requirements of manufacturing or processing activities. • Formal risk assessment techniques can result in a scientifically valid contamination control program. 2017/3/4 13
  • 14. USP39 <1116> ESTABLISHMENT OF SAMPLING PLAN AND SITES 2017/3/4 14
  • 15. Sampling Time • Sampling should take place with the facility in the operational condition (personnel present and normal operations being carried out). • Microbial sampling should occur when materials are in the area, processing activities are ongoing, and a full complement of personnel is working within the aseptic processing environment. • The operational condition for sterile hoods and transfer devices can be considered to be when an operator is working in any part of the clean air device. • Sampling in the static condition should be performed at an agreed frequency to monitor baseline contamination levels. 2017/3/4 15
  • 16. Sampling Sites • Microbial monitoring of manufacturing clean rooms, RABS, and isolators should include compressed gases, surfaces, room or enclosure air, and any other materials and equipment that might produce a risk of contamination. • The location and movement of personnel within the clean room correlate with contamination risk to the environment and to the processes conducted within that environment. • The location and movement of personnel within the clean room correlate with contamination risk to the environment and to the processes conducted within that environment. 2017/3/4 16
  • 17. Methods of EMM • Air - Air sampler(active method): testing of the number of organisms per volume of air sampled. -Settling plate(passive method): settling plates can be used as qualitative, or semi-qualitat • Surface -Contact plate: product contact surface, floors, walls, and equipment should be tested on a regular basis. -Swabbing 2017/3/4 17
  • 18. Air Sampler (Viable airborne particulates) Active Air Monitoring ISO 14644, Fed Std-209E, USP <1116> • Used to sample a defined volume of air, embedding viable particulates onto sterile media strips. • The media strips are incubated to promote the growth of viable particulates • The microorganisms are counted and results are reported as the number of CFU per volume of air sampled. 2017/3/4 18
  • 19. Settling Plates (Viable airborne particulates) Passive Air Monitoring ISO 14644, Fed Std-209E, USP <1116> • Settling plates filled with media are used to sample the microbial fallout over time. • The plates are incubated to promote growth • Microorganisms are counted and results are reported as the number of CFU per time sampled. • The average size of microbial particle will deposit, by gravity, onto surfaces at a rate of approximately 1 cm/s. 2017/3/4 19
  • 20. Sampling Sites for Settling Plates • Areas where there is little air movement (i.e. "dead spaces") or where airflows converge or are excessively turbulent. These conditions are most likely to occur: – adjacent to doors – in pass through hatches – at low level return air grilles – between HEPA's in clean rooms – in corners of rooms • Areas within the clean room where there is personnel activity or where specific operations are carried out. 2017/3/4 20
  • 21. RODAC Plates (Viable, Surface-Bound Particles) Surface Monitoring ISO 14644, Fed Std-209E, USP <1116> • Contact plates (RODAC Plates) filled with media are used to sample tabletops, walls, benches, floors, garments, and gowned personnel. • Measure the number of microorganisms per area sampled. • Plates are incubated to promote growth, the microorganisms are counted and results are reported as the number of CFU per area sampled. 2017/3/4 21
  • 22. RODAC (Replicate Organism Detection and Counting) • flat agar surface is above the edges of the dish (so you can press it on flat surfaces) and a grid, allowing counting of cfu per cm². 2017/3/4 22
  • 23. RODAC Plates • One objective of surface sampling is to determine the efficiency of routine cleaning procedures in removing contamination. - Sampling is done before and after cleaning. - The medium in the plates contains neutralizing agents, which inactivate residual disinfectants on the surface to be tested, allowing comparative results before and after cleaning. • RODAC plates are also used to monitor the contamination level of personnel gowns and Personal Protective Equipment (PPE) before or during manufacturing production. 2017/3/4 23
  • 24. Swabbing method (Viable, Surface-Bound Particles) Surface Monitoring ISO 14644, Fed Std-209E, USP <1116> • The swabbing method can be used to supplement contact plates for sampling of irregular surfaces, especially irregular surfaces of equipment. • The area that will be swabbed is defined with a sterile template of appropriate size. • In general, it is in the range of 24–30 cm2. • After sample collection the swab is placed in an appropriate diluent or transport medium and is plated onto the desired nutrient agar. 2017/3/4 24
  • 26. Rapid Microbiological Methods Contact Slide(25cm2) Petrifilm plate • USP<61> <62> <71> <1227> 2017/3/4 26
  • 27. Growth Media • Use a growth medium with low selectivity i.e. capable of supporting a broad spectrum of microorganisms including bacteria, fungi, yeast and molds. - SCDM(TSA) is suitable for environmental monitoring in most cases because it supports the growth of a wide range of bacteria, yeast, and molds. - Sabouraud Dextrose Agar (SDA) supports yeast and fungal colonies. 2017/3/4 27
  • 28. Growth Media • When necessary to detect or search for a particular type of microorganism a selective culture medium should be used. - Malt Extract Agar(MEA) is used as a general purpose growth media to isolate and cultivate yeasts and molds from clinical samples, as well as a wide range of environmental sources. 2017/3/4 28
  • 29. Culture Condition USP 39 <1116> • Typically, for general microbiological growth media such as SCDM, incubation temperatures in the ranges of approximately 20 –35℃ have been used with an incubation time of not less than 72 hours. • The temperature ranges given above are by no means absolute. • For many mesophilic organisms, recovery is possible over a range of approximately 20℃ . 2017/3/4 29
  • 30. Culture Condition USP 39 <1116> •In the absence of confirmatory evidence, microbiologists may incubate a single plate at both a low and a higher temperature. Incubating at the lower temperature first may compromise the recovery of Gram(+) cocci that are important because they are often associated with humans. •Typically, for general microbiological growth media such as SCDM, incubation temperatures in the ranges of approximately 20–35℃ have been used with an incubation time of not less than 72 hours. - TSA plates are incubated at 30-35°C for 3 days. - SDA plates are incubated at 20-25°C for 5 days. (A review of cleanroom microflora: Types, treans, and Pattens. PDA J Pharm Sci Technol ,2011) 2017/3/4 30
  • 31. Identification • FDA Pharmaceutical CGMPs, 2004 2017/3/4 31
  • 32. • FDA Pharmaceutical CGMPs, 2004 2017/3/4 32
  • 33. • USP 39 <1116> Identification of microbial isolates 2017/3/4 33
  • 38. USP39 <1117> • Special care should be taken with media that is used in environmental monitoring studies. Media used for environmental monitoring of critical areas should preferably be double-wrapped and terminally sterilized. If terminal sterilization is not performed, media should be subjected to pre-incubation and 100% inspection prior to use within a critical area. This will prevent extraneous contamination from being carried into controlled environments and will prevent false-positive results. A raised agar level for surface contact plates should be verified. 2017/3/4 38